Warren Foust - 12 Mar 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Interim Co-CEO and Pres. & COO
Signature
/s/ Warren Foust
Issuer symbol
STAA
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 17:00:16 UTC
Previous filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Foust Warren Interim Co-CEO and Pres. & COO 25510 COMMERCENTRE DRIVE, LAKE FOREST /s/ Warren Foust 16 Mar 2026 0001970778

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise +8,175 +31% $0.000000* 34,263 12 Mar 2026 Direct F1
transaction STAA Common Stock Options Exercise +19,550 +57% $0.000000* 53,813 14 Mar 2026 Direct F3
transaction STAA Common Stock Options Exercise +9,775 +18% $0.000000* 63,588 14 Mar 2026 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Options Exercise -8,175 -50% $0.000000* 8,175 12 Mar 2026 Common Stock 8,175 $0.000000 Direct F1, F6
transaction STAA Restricted Stock Units Award +45,117 $0.000000* 45,117 13 Mar 2026 Common Stock 45,117 $0.000000 Direct F2, F6
transaction STAA Restricted Stock Units Options Exercise -19,550 -33% $0.000000* 39,101 14 Mar 2026 Common Stock 19,550 $0.000000 Direct F3, F6
transaction STAA Restricted Stock Units Options Exercise -9,775 -33% $0.000000* 19,551 14 Mar 2026 Common Stock 9,775 $0.000000 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027.
F2 Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (15,039 shares) on March 13, 2027, 1/3 (15,039 shares) on March 13, 2028, and 1/3 (15,039 shares) on March 13, 2029.
F3 Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028.
F4 Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028.
F5 Includes previously granted RSUs, which are subject to future vesting.
F6 Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.